Bulletin from the Extraordinary General Meeting of Diagonal Bio AB on 17 January 2025 January 18, 2025
Diagonal Bio enters into a strategic partnership with Daniel Redén at StallZet to enhance commercialisation plans December 23, 2024
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell December 14, 2024
Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences October 25, 2024